COO logo

COO The Cooper Companies, Inc.

NASDAQ Global Select · Medical - Instruments & Supplies · Healthcare

$56.91
-0.50 (-0.87%)

The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses su…

Market Cap: $11.10Bwww.coopercos.com

Price

$76.22+7.32%
$68.51$71.28$74.05$76.82
Jul 9Aug 21

Social Signal Score

39
5d
28
4 mentions
+0.0%
30d
42
28 mentions
+0.0%
60d
43
43 mentions
+2.7%
90d
43
43 mentions
+9.5%
rss: 12 · news: 29 · marketaux: 2

Analyst Ratings

28 analysts
Buyconsensus
Strong Buy 0Buy 14Hold 13Sell 1Strong Sell 0
Avg price target$65.75+15.5%
Low $59Median $63.5High $75
Current Consensus

52-week range

$58.98$84.32
Last close
$76.22
Off 52w high
-9.6%
200-day average
$73.35
vs 200-day
+3.9%

Revenue

$1.07B+105.57%
$499.10M$693.23M$887.37M$1.08B
Oct 2016Jul 2026

Analyst Estimates

FY2025
$4.10
$4.09–$4.11
12 analysts
FY2026
$4.54+11% YoY
$4.53–$4.55
11 analysts
FY2027
$4.71+4% YoY
$4.56–$4.89
11 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Albert G. White
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
15,000
Beta
0.82
Country
US
Piotroski score
7 / 9 (Strong)
Altman Z-score
2.94
www.coopercos.com